As COVID-19 positivity rates rise in the city and surrounding areas, hospital leaders are on high alert, with the spring’s surge still fresh on their minds.

The research, which was announced this week by Columbia University professor Frank Lichtenberg, found that patients are 2.5% more likely to start and stay on a course of treatment for every 10-year decrease in a drug's time on the market.

A new study from researchers at the Icahn School of Medicine at Mount Sinai suggests that the presence of COVID-19 antibodies in the city is around 22%, still a ways off from the level that would indicate herd immunity.

The study is supported by a $2.5 million award from the U.S. Department of Defense through the medical technology enterprise consortium. The award is part of the consortium's efforts to keep military personnel healthy by detecting the virus before symptoms emerge.

Revenue for the three months ended Sept. 30 totaled $2.8 billion—a 42.5% increase from the prior-year period. Earnings for the nine months ended Sept. 30 totaled $6.4 billion—an 11% increase from the previous year.

Northwell Health's $2.5 billion expansion plan for the hospital in Manhattan's Upper East Side, one of New York City's whitest enclaves, faces vehement opposition from healthcare advocates who say the project neglects communities of color.

Manhattan-based biometrics firm Clear—best known for letting people skip to the front of the airport security line—has partnered with the country's two largest private labs to link COVID-19 test results to an app that lets employers and building owners screen at the door for health risks. 

The Downtown Brooklyn hospital, an affiliate of Mount Sinai Health System, seeks to tear down two buildings with about 50,000 square feet, replacing them with two towers providing about 800,000 square feet, CEO Gary Terrinoni said.

The work is especially important as antiretroviral therapy to suppress HIV has helped tens of millions of people live longer and healthier lives. But the unfortunate consequence of living longer with HIV is an increased risk of cancer.

The biggest example of overspending found in the audits, issued Sept. 17 by New York Comptroller Thomas DiNapoli, was $605 million on overly expensive drugs from 2016 to 2019. 

The goal is to have more than 85% of labor and delivery personnel complete a range of emergency simulations on an ongoing basis, the health system said. 

Commercial ambulance providers in New York are used to a small number of calls for which they treat patients at home who don’t need or want to be taken to a hospital. Such instances have skyrocketed during the pandemic, however, and the companies aren’t being reimbursed for them.

Oscar, headquartered in New York City, has enrolled about 70,000 South Florida members in individual and family plans since its entry into the region six months ago, and 121,000 members across the state.

New York insurers also had to instruct healthcare providers to refund PPE fees charged to patients and to inform their insured members that they cannot be charged those fees during visits.

With events canceled during the pandemic, Paradocs has found a lifeline in conducting daily temperature checks and facilitating COVID-19 testing for companies as New Yorkers start returning to work.